Zhaoyan New Drug 2024 Target Price
The target price of Zhaoyan New Drug in 2024 was about 19.6 yuan (Guotai Junan released a research report on November 3). In the past month, Zhaoyan New Drug had received the attention of two research reports from stockholders, with an average target price of 21.30 yuan.
Zhaoyan New Drug 10.02% Limit
On November 4, 2024, Zhaoyan New Drug (603127) closed at 18.66 yuan, up 10.02%, reaching the limit. At 9:39 on the same day, Zhao Yan New Drug hit the limit and did not open. As of the closing date, the fund was 60.0905 million yuan, accounting for 0.51% of its current market value. In terms of capital flow on that day, the main net capital flow was 102 million yuan, accounting for 42.46% of the total turnover, the net outflows of hot money funds were 43.2413 million yuan, accounting for 17.96% of the total turnover, and the net outflows of individual investors were 58.9723 million yuan, accounting for 24.5% of the total turnover. Zhao Yan's new drug was a hot stock for gene editing, stem cells, and CAR-T therapy concepts. On that day, these concepts rose by 2.87%, 2.55%, and 2.08%, respectively. The medical service industry was also in a rising state, led by Sanbo Brain.
Zhaoyan New Drug bought on March 14
Zhao Yan New Drug was bought by foreign capital, the main capital, and the sales department on March 14th. Specifically, foreign investors bought 23,900 shares, the main capital bought 81,934,400 yuan, and the sales department seats bought 62,716,800 yuan. These data showed that Zhao Yan's new drug had received the attention and purchase of many funds on that date.
Zhaoyan's new drug is on the market
Zhaoyan New Drug was listed on the Shanghai stock exchange in 2017. At 9:30 a.m. on February 26,2021, it was successfully listed on the main board of the Hong Kong stock exchange.
Zhaoyan's New Drug Launch Time
Zhao Yan New Drug was listed on the main board of the A-share Shanghai Exchange on August 25th, 2017, and listed on Hong Kong stocks on February 26th, 2021.
Target Price for 2021
The research report issued by Capital Security on December 21, 2021 maintained a 360 buy rating with a target price of 20.99 yuan. The novel " Mother-in-law of the 60s and Daughter-in-law of the 80s " is equally exciting. Everyone is welcome to click and read it!
Target Price: 2024
Different sources had different opinions on 360's 2024 target price. Some people think that the long-term target price is 1000 yuan, and there is also a 2024 target price of 6 yuan. Some dealers give a target price range of 15 yuan to 20 yuan. However, the exact price would be affected by the macro economic environment, market sentiment, and other unforeseen factors. The novel "Mother-in-law of the 60s and Daughter-in-law of the 80s" is equally exciting. Everyone is welcome to click and read it!
Target Price in 2024
Different sources had different opinions on 360's 2024 target price. Some of the target price ranges given by some of the firms were between 15 yuan and 20 yuan, while others believed that their 2024 target price was 6 yuan. However, the specific price of the stock would be affected by the macro economic environment, market sentiment, and other unforeseen factors. The novel " Mother-in-law of the 60s and Daughter-in-law of the 80s " is equally exciting. Everyone is welcome to click and read it!
Target price for 2020
Citic Security gave 263 a valuation of 45 times in 2020, with a corresponding target price of 7.2 yuan; another analysis gave the online education leader 263 a target price of 35.44 yuan. The novel " Mother-in-law of the 60s and Daughter-in-law of the 80s " is equally exciting. Everyone is welcome to click and read it!
2025 Target Price
Some data mentioned that the target price of 360 stocks in 2025 was 350 yuan, while others mentioned that the target price exceeded 66 yuan. However, these were only analysis and predictions. The actual trend of stock prices was affected by many complicated factors.
2024 Target Price
Some institutions predicted that the average target price was 42.37 USD/share (as of December 3,2024, Eastern Time), the highest target price was 47.59 USD/share, and the lowest target price was 36.79 USD/share. There was also a target price of 6 yuan in 2024 (currency not specified).